Delivery Order SPE2DB22D1106-SPE2DB24FFAV5
Award Date
7/8/24
Potential Completion Date
7/9/24
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,162.65, is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with an ultimate completion date of October 31, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,567.40, is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a completion date of February 10, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $11,767.52, is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $4,905.57, is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a Ceiling Value of $6,622.24. The contract is for a Firm Fixed Price and has an Ultimate Completion Date of March 31, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $16,678.02, is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a period of performance through January 10, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a ceiling value of $17,536.76 and a period of performance through June 26, 2024. The contract is a delivery order, with a firm fixed price pricing type. This award is not associated with a set-aside program. AmerisourceBergen Drug...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies, with a ceiling value of $15,377.81 and a completion date of October 29, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not designated with a set-aside. Amerisourcebergen holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a ceiling value of $11,426.86 and a performance period extending until June 17, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a ceiling value of $4,105.40 and a period of performance through April 4, 2025. The contract has a Firm Fixed Price pricing type and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...